Company News For Oct 11, 2017

• Shares Barracuda Networks, Inc. CUDA gained 0.04% after posting second quarter 2018 revenues of $94 million, surpassing the Zacks Consensus Estimate of $93 million

• Merck & Co., Inc.’s MRK shares gained 0.2% after the company purchased a 9.9% stake in KalVista Pharmaceuticals Inc. KALV at a price of $8.50 per share

• AnaptysBio, Inc.’s ANAB shares rallied 101.2% after the company announced positive results and proof-of-concept data from Phase 2a trial of it drug ANB020 In used for the treatment atopic dermatitis

• Shares of Hudson Technologies Inc. HDSN declined 0.8% after the company lowered its third quarter 2017 earnings guidance to $0.03-$0.05 a share from $0.10 per share earlier

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Barracuda Networks, Inc. (CUDA) : Free Stock Analysis Report
 
Merck & Company, Inc. (MRK) : Free Stock Analysis Report
 
Hudson Technologies, Inc. (HDSN) : Free Stock Analysis Report
 
AnaptysBio, Inc. (ANAB) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research